Earnings Call · Q1 FY2021·2021-05-05

Q1 21EPS +20.75%·Rev n/aQ4 20EPS +10.64%·Rev n/aQ3 20EPS -42.11%·Rev n/aQ2 20EPS +37.21%·Rev n/a⚠ consensus missing

ACADIA PHARMACEUTICALS INC ACAD

Mark Johnson — Senior Executive (likely Investor Relations or Corporate Communications)

Stephen Davis — Chief Executive Officer

Amanda Morgan — Senior Executive (likely in Commercial or Medical Affairs)

Charmaine Lykins — Senior Executive (likely Commercial or Marketing)

Srdjan Stankovic — Senior Executive (likely Chief Medical Officer or similar)

Elena Ridloff — Senior Executive (likely Chief Financial Officer)

−0.6%1d on move date3d+7.9%5d+6.8%

Research tier

Behavioral profile computed for 6 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ACAD calls or request research access.

More ACAD calls Browse calls Request research access